Abstract:Background: Hyperuricemia (HUA) is becoming a global public health problem and associated with multiple diseases. Objective: We conducted a systematic review to synthesize the pooled prevalence of HUA in mainland China and delineate its demographic, regional, and temporal trends over the past two decades. Methods: Systematic literature searches of PubMed, SCOPUS, Web of Science, the China National Knowledge Infrastructure (CNKI), and the Wanfang digital database were conducted to screen studies published from 1 January 2000 to 31 August 2019, reporting the prevalence of HUA in mainland China. The search strings were ('hyperuricemia' OR 'hyperuricaemia' OR 'uric acid') AND ('prevalence' OR 'epidemiology') AND 'China'. Article quality was appraised quantitatively from 11 items. Before formal meta-analysis, age-standardized prevalence was transformed. The random-effects model was applied to synthesize the pooled prevalence due to its high heterogeneity. Then we stratified the prevalence estimates by age, gender, area, nationality, and publication year for subgroup analysis. Results: Totally 177 eligible studies with a whole population of 2,277,712 were included in the present meta-analysis. The pooled prevalence in mainland China was estimated at 16.4% (95% CI: 15.3%similar to 17.6%). In studies with the onset age at 20 similar to 29 years old, males had a twice times higher HUA prevalence than females (21.5% vs. 8.9%). The prevalence of HUA was 13.7% (11.8%similar to 15.7%) in people aged 15 similar to years old, 16.5% in 30 similar to (14.8%similar to 18.4%), 17.9% in 40 similar to (16.4%similar to 19.5%), 19.4% in 50 similar to (17.8%similar to 21.0%), 20.5% in 60 similar to (18.8%similar to 22.3%), and 24.9% in over 70 (22.9%similar to 27.1%). Stratified by regions, southern (25.5%) and southwestern (21.2%) China shared the highest prevalence, and the lowest prevalence was observed in the northwest (12.6%). From 2001 to 2017, the prevalence estimates of HUA steadily climbed from 8.5% to 18.4% with minor fluctuations. Multiple regression revealed that HUA prevalence was positively correlated to the larger sample size, area, advanced onset age, and published year. Conclusions: The last two decades witnessed the rapid growth prevalence of HUA in China. Early screening and personalized health education for HUA need to be given enough attention.

Prevalence and risk factors of hyperuricemia and gout: a cross-sectional survey from 31 provinces in mainland China

Prevalence and Risk Factors of Hyperuricaemia in Non-Obese Chinese: a Single-Centre Cross-Sectional Study

Hyperuricemia prevalence and its association with metabolic disorders: a multicenter retrospective real-world study in China

Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19

Demographic, Regional and Temporal Trends of Hyperuricemia Epidemics in Mainland China from 2000 to 2019: a Systematic Review and Meta-Analysis

Prevalence of and Risk Factors for Hyperuricemia in Urban Chinese Check‐Up Population

Prevalence and Correlates of Hyperuricemia in the Middle-Aged and Older Adults in China

Association between Serum Uric Acid and Pre-hypertension and Hypertension among Chinese Adults

Prevalence and associated factors of hyperuricemia among urban adults aged 35–79 years in southwestern China: a community-based cross-sectional study

The Prevalence of Hyperuricemia in A Population of the Coastal City of Qingdao, China

Prevalence and Risk Factors of Hyperuricemia in the Urban Health Checkup Population in Xinjiang, China: A Cross-Sectional Study

The prevalence of gout and hyperuricemia in middle-aged and elderly people in Tibet Autonomous Region, China A preliminary study

Prevalence and risk factors of hyperuricemia: results of the Kailuan cohort study.

The prevalence of gout in mainland China from 2000 to 2016: a systematic review and meta-analysis

Epidemiology and prevalence of hyperuricemia among men and women in Chinese rural population: The Henan Rural Cohort Study

The prevalence of hyperuricemia and its correlates in Ganzi Tibetan Autonomous Prefecture, Sichuan Province, China

Incidence and Risk Factors of Hyperuricemia among 2.5 Million Chinese Adults during the Years 2017–2018

Prevalence and Related Factors of Hyperuricaemia in Chinese Children and Adolescents: a Pooled Analysis of 11 Population-Based Studies

Clinical Value Of Serum Lipid Profile And Renal Function For The Management Of Hyperuricemia In Adults In Southern China

Hyperuricemia and the metabolic syndrome in Hangzhou.

Triglycerides and Total Cholesterol Concentrations in Association with Hyperuricemia in Chinese Adults in Qingdao, China